Inflammation and gut dysbiosis as drivers of CKD-MBD
- PMID: 37488276
- DOI: 10.1038/s41581-023-00736-7
Inflammation and gut dysbiosis as drivers of CKD-MBD
Abstract
Two decades ago, Kidney Disease: Improving Global Outcomes coined the term chronic kidney disease-mineral and bone disorder (CKD-MBD) to describe the syndrome of biochemical, bone and extra-skeletal calcification abnormalities that occur in patients with CKD. CKD-MBD is a prevalent complication and contributes to the excessively high burden of fractures and cardiovascular disease, loss of quality of life and premature mortality in patients with CKD. Thus far, therapy has focused primarily on phosphate retention, abnormal vitamin D metabolism and parathyroid hormone disturbances, but these strategies have largely proved unsuccessful, thus calling for paradigm-shifting concepts and innovative therapeutic approaches. Interorgan crosstalk is increasingly acknowledged to have an important role in health and disease. Accordingly, mounting evidence suggests a role for both the immune system and the gut microbiome in bone and vascular biology. Gut dysbiosis, compromised gut epithelial barrier and immune cell dysfunction are prominent features of the uraemic milieu. These alterations might contribute to the inflammatory state observed in CKD and could have a central role in the pathogenesis of CKD-MBD. The emerging fields of osteoimmunology and osteomicrobiology add another level of complexity to the pathogenesis of CKD-MBD, but also create novel therapeutic opportunities.
© 2023. Springer Nature Limited.
Similar articles
-
Current therapeutic approach of chronic kidney disease-mineral and bone disorder.Ther Apher Dial. 2024 Oct;28(5):671-689. doi: 10.1111/1744-9987.14177. Epub 2024 Jun 19. Ther Apher Dial. 2024. PMID: 38898685 Review.
-
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).Am J Kidney Dis. 2017 Dec;70(6):737-751. doi: 10.1053/j.ajkd.2017.07.019. Epub 2017 Sep 21. Am J Kidney Dis. 2017. PMID: 28941764
-
Role of Chronic Kidney Disease (CKD)-Mineral and Bone Disorder (MBD) in the Pathogenesis of Cardiovascular Disease in CKD.J Atheroscler Thromb. 2023 Aug 1;30(8):835-850. doi: 10.5551/jat.RV22006. Epub 2023 May 30. J Atheroscler Thromb. 2023. PMID: 37258233 Free PMC article. Review.
-
Mechanistic insights into CKD-MBD-related vascular calcification and its clinical implications.Life Sci. 2022 Dec 15;311(Pt B):121148. doi: 10.1016/j.lfs.2022.121148. Epub 2022 Nov 3. Life Sci. 2022. PMID: 36336124 Review.
-
Emerging cross-talks between chronic kidney disease-mineral and bone disorder (CKD-MBD) and malnutrition-inflammation complex syndrome (MICS) in patients receiving dialysis.Clin Exp Nephrol. 2022 Jul;26(7):613-629. doi: 10.1007/s10157-022-02216-x. Epub 2022 Mar 30. Clin Exp Nephrol. 2022. PMID: 35353283 Free PMC article. Review.
Cited by
-
Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease.J Clin Med. 2024 Jul 6;13(13):3967. doi: 10.3390/jcm13133967. J Clin Med. 2024. PMID: 38999530 Free PMC article.
-
Mesoporous activated carbon derived from Chinese herbal medicine residues for hemoperfusion removal of uremia toxins from progressive chronic kidney diseases patients.Heliyon. 2024 Oct 2;10(20):e38892. doi: 10.1016/j.heliyon.2024.e38892. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39498034 Free PMC article.
-
Food to Prevent Vascular Calcification in Chronic Kidney Disease.Nutrients. 2024 Feb 23;16(5):617. doi: 10.3390/nu16050617. Nutrients. 2024. PMID: 38474744 Free PMC article. Review.
-
Mizhuo Guanchangye enema delays the decline of renal function in rats with chronic kidney disease by intervening in the TLR4/MyD88/NF-κB pathway.Front Med (Lausanne). 2024 Oct 28;11:1454506. doi: 10.3389/fmed.2024.1454506. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39529796 Free PMC article.
-
Application of artificial intelligence to chronic kidney disease mineral bone disorder.Clin Kidney J. 2024 Jun 6;17(6):sfae143. doi: 10.1093/ckj/sfae143. eCollection 2024 Jun. Clin Kidney J. 2024. PMID: 38899159 Review.
References
-
- Sarnak, M. J. et al. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 74, 1823–1838 (2019). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical